Skandinaviska Enskilda Banken (SEB)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-94,646
Closed -$9.65M 1004
2023
Q2
$9.65M Buy
+94,646
New +$9.65M 0.06% 271